Abstract
Imaging the living brain and the distribution of the ligand gated channels that participate in the neurotransmission is one of the challenges that is hoped to bring new insights for the treatment of neurological diseases. Herein, we probed a new nicotinic derivative, A-186253 as a potential molecule to discriminate with high resolution the different neuronal nicotinic receptor subtypes that are expressed in distinct brain areas. Binding with a high affinity of 440 pM at the major brain alpha4beta2 receptor subtype and presenting an excellent safety margin, properties of the A-186253 were thoroughly evaluated. While autoradiography confirmed its specificity for the alpha4beta2 subtype, functional investigations revealed for short exposures a broader spectrum of action at receptors including the ganglionic alpha3beta4 and the homomeric alpha7 subtypes. Specificity was, however, observed at alpha4beta2 when receptors were exposed for several minutes with low concentration of the A-186253. In view of these promising results, the A-186253 was radiolabeled and tested in positron emission tomography on rats and pigs. Despite the high selectivity observed in vitro, the A-186253 displayed a complex binding profile and little displacemen...Continue Reading
References
Apr 5, 1988·Biochemistry·J Langenbuch-CachatJ P Changeux
Mar 1, 1988·Journal of Medicinal Chemistry·R C YoungN E Sore
Nov 1, 1993·The Journal of Membrane Biology·A Devillers-ThiéryJ P Changeux
Aug 1, 1995·European Journal of Biochemistry·J BretonI Prieto
Jan 31, 1995·Biochemistry·T L Lentz
Sep 1, 1994·Journal of Pharmaceutical Sciences·M H AbrahamR C Mitchell
May 1, 1997·Nuclear Medicine and Biology·P J BlowerE M Link
Jul 1, 1997·European Journal of Nuclear Medicine·H LundqvistA Nordberg
Nov 19, 1997·Progress in Neurobiology·C GottiF Clementi
Dec 1, 1998·British Journal of Pharmacology·S BertrandD Bertrand
Dec 18, 1998·Neuron·J P Changeux, S J Edelstein
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·N H LinM W Holladay
Mar 30, 1999·Nuclear Medicine and Biology·Y S DingF I Carroll
Sep 29, 1999·Neuroscience·M V SkokV I Skok
Mar 23, 2001·Acta Neurologica Scandinavica. Supplementum·W SihverA Nordberg
Aug 16, 2001·Trends in Biochemical Sciences·T Grutter, J P Changeux
Aug 24, 2001·Nuclear Medicine and Biology·J T PattG Westera
Apr 3, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Masahiro FujitaRobert B Innis
May 31, 2002·Neurophysiologie clinique = Clinical neurophysiology·Valérie Itier, Daniel Bertrand
Jul 12, 2002·Synapse·Michael KassiouBernard Maziere
Jul 18, 2002·Epilepsia·D BertrandJ Mulley
Jul 20, 2002·Annals of Nuclear Medicine·Hideo SajiTakahiro Mukai
Nov 19, 2002·Journal of Neurobiology·Nicolas Le NovèreJean-Pierre Changeux
Jan 31, 2003·Synapse·Svetlana I CheferAlexey G Mukhin
Feb 4, 2003·Journal of Neurochemistry·Li JiaBruce N Cohen
Citations
Sep 13, 2006·Biochemistry·David L ShiembobJ Michael McIntosh
Jun 28, 2005·The European Journal of Neuroscience·Marzia LecchiDaniel Bertrand
Feb 9, 2010·British Journal of Pharmacology·M UedaH Saji
Mar 1, 2006·Molecular Pharmacology·Galya R AbdrakhmanovaBilly R Martin
Jun 26, 2009·Journal of the American Chemical Society·Xiaoqin HuangChang-Guo Zhan
Jul 22, 2005·Journal of Medicinal Chemistry·Anders A JensenPovl Krogsgaard-Larsen